This company listing is no longer active
A281310 Stock Overview
Bio-Synectics, Inc. provides drug delivery system solutions for the solubility of active ingredients in pharmaceutical, nutraceutical, and cosmetic products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Bio-Synectics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩415.00 |
| 52 Week High | ₩850.00 |
| 52 Week Low | ₩365.00 |
| Beta | 0 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -95.23% |
| 5 Year Change | -95.87% |
| Change since IPO | -97.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| A281310 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | -15.1% | -2.4% | -1.6% |
| 1Y | n/a | -1.8% | 2.1% |
Return vs Industry: Insufficient data to determine how A281310 performed against the KR Life Sciences industry.
Return vs Market: Insufficient data to determine how A281310 performed against the KR Market.
Price Volatility
| A281310 volatility | |
|---|---|
| A281310 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.9% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A281310 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine A281310's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | n/a | www.bio-synectics.com |
Bio-Synectics, Inc. provides drug delivery system solutions for the solubility of active ingredients in pharmaceutical, nutraceutical, and cosmetic products. It offers hydroparticle products; nutraceutical products, such as HydroCoQ10, which enable solution-like dispersion of CoQ10 for use in various products with bioavailability; HydroCurcumin, which enable solution-like dispersion of curcumin for use in various products with bioavailability; HydroMilkthistle, a natural herb used to treat liver disorders; HydroCosanol, a solubilized octacosanol product used in various types of foods and beverages; HydroPS, a solubilized phosphatidylserine product used in various types of foods and beverages; and cosmetic hydroparticle ingredients. The company was founded in 2004 and is based in Seoul, South Korea.
Bio-Synectics, Inc. Fundamentals Summary
| A281310 fundamental statistics | |
|---|---|
| Market cap | ₩1.09b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A281310 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A281310 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A281310 perform over the long term?
See historical performance and comparison